Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-25
2006-04-25
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S235500, C514S253120, C514S326000, C544S129000, C544S360000, C546S216000, C546S210000, C546S221000
Reexamination Certificate
active
07034042
ABSTRACT:
Compounds of formula (I) in free or salt form, where Ar1is phenyl substituted by one or more substituents selected from halogen, cyano, nitro, and C1–C8-alkyl optionally substituted by cyano or halogen, Ar2is phenyl optionally which is unsubstituted or substituted by one or more substituents selected from halogen, cyano, hydroxy, nitro, C1–C8-alkyl, C1–C8-haloalkyl, C1–C8-alkoxy or C1–C8-alkoxycarbonyl, R1is C1–C8-alkyl substituted by hydroxy, C1–C8-alkoxy, acyloxy, —N(R2)R3, halogen, carboxy, C1–C8-alkoxycarbonyl, phenyl-C1–C8-alkoxycarbonyl, —CON(R4)R5or by a monovalent cyclic organic group, R2and R?3are each independently hydrogen or C1–C8-alkyl, or R2is hydrogen and R3is acyl or SO2R6, or R2and R3together with the nitrogen atom to which they are attached denote a 5- or 6-membered heterocyclic group, R4and R5are each independently hydrogen, C1–C8-alkyl optionally substituted by hydroxy or phenyl, or phenyl optionally substituted by C1–C8-alkyl, halogen, cyano or C1–C8-alkoxy, or R4and R5together with the nitrogen atom to which they are attached denote a 5- or 6-membered heterocyclic group, R?6is C1–C8-alkyl, C1–C8-haloalkyl, or phenyl optionally substituted by C1–C8-alkyl, and n is 1, 2, 3 or 4. The compounds are useful as pharmaceuticals.
REFERENCES:
patent: 4673684 (1987-06-01), Wakabyashi et al.
patent: 4795752 (1989-01-01), Hattori et al.
patent: 6670379 (2003-12-01), Howe et al.
patent: 197 56 235 (1999-07-01), None
patent: 0 399 569 (1990-11-01), None
patent: 63 179869 (1988-07-01), None
patent: 88/04169 (1988-06-01), None
patent: 00/58305 (2000-10-01), None
Rollins BJ. Blood. 1997, 90(3): 909-928.
Hesselgesser et al. J. Biol. Chem. 1996, 273 (25) :15687-15692.
Bhalay Gurdip
Howe Trevor J
Le Grand Darren M
Chang Celia
Houghton Gregory C.
Novartis AG
LandOfFree
N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR33... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR33..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR33... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3610901